Kamada KMDA
NASDAQ KMDA
$8.08 +0.19 (+2.44%)
At close: Aug 20, 2026 · 1:55 PM UTC

Kamada (KMDA) Liabilities and Shareholders Equity (2012 - 2026)

Kamada's (KMDA) quarterly Liabilities and Shareholders Equity came in at $383.0 million in Q1 2026, up 2.11% YoY from $375.1 million in Q1 2025, and up 1.14% on a QoQ basis from $378.7 million in Q4 2025.

Kamada (KMDA) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

Kamada (KMDA) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $383.0 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 2.11% year-over-year to $383.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 3.97% YoY) and the FY2025 annual result came in at $378.7 million, up 1.73% from the prior year.
  • Liabilities and Shareholders Equity climbed to $383.0 million in Q1 2026, from $378.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $343.2 billion in Q1 2024 to a low of $303.1 million in Q1 2022.
  • A 5-year average of $77.7 billion and a median of $372.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 147519.93% — and 2024, when it plunged 99.9%.
  • Tracing KMDA's Liabilities and Shareholders Equity over 5 years: stood at $322.4 million in 2022, then rose by 10.09% to $354.9 million in 2023, then increased by 4.89% to $372.3 million in 2024, then increased by 1.73% to $378.7 million in 2025, then increased by 1.14% to $383.0 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $383.0 million (Q1 2026), $378.7 million (Q4 2025), and $377.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 6.18 Bn
10 Kamada 465.93 Mn 436.45 Mn 22.47 Mn 383.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 383.16 Mn
Mar 31, 2026 383.02 Mn
Dec 31, 2025 378.71 Mn
Sep 30, 2025 377.21 Mn
Jun 30, 2025 368.17 Mn
Mar 31, 2025 375.11 Mn
Dec 31, 2024 372.26 Mn
Sep 30, 2024 351.21 Mn
Jun 30, 2024 351.04 Mn
Mar 31, 2024 343.17 Bn
Dec 31, 2023 354.91 Mn
Sep 30, 2023 337.06 Bn
Jun 30, 2023 314.39 Mn
Mar 31, 2023 316.80 Bn
Dec 31, 2022 322.38 Mn
Sep 30, 2022 319.64 Bn
Jun 30, 2022 304.14 Mn
Mar 31, 2022 303.10 Mn
Dec 31, 2021 318.67 Mn
Sep 30, 2021 216.53 Mn